Mark Jeffrey DeLong - 20 Oct 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Senior Vice President
Signature
/s/ David Watson, attorney-in-fact for Mark Delong
Issuer symbol
APLS
Transactions as of
20 Oct 2021
Net transactions value
$0
Form type
4
Filing time
27 Oct 2021, 16:26:20 UTC
Previous filing
22 Jul 2021
Next filing
07 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +882 +9.3% $0.000000 10,372 20 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit that vest 50% annually over two years from grant date, subject to continued service.